Shots:
- Hims & Hers has entered into a definitive agreement to acquire Eucalyptus, to expand into Australia and Japan, and deepen its presence in the UK, Germany, and Canada
- As per the deal, Hims & Hers will acquire Eucalyptus for up to ~$1.15B, including upfront ~$240M in cash
- The acquisition is expected to close mid-2026, pending regulatory approvals and customary conditions
Ref: Hims & Hers | Image: Eucalyptus | Press Release
Related News: Hims & Hers Launches Multi-Cancer Blood Test by Galleri
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
